Mounjaro (tirzepatide): The newest diabetes and obesity medication (explanation and overview) [l7XKPfE30]
Tirzepatide (brand name: Mounjaro) is the newest injectable medication for the treatment of type II diabetes and obesity. Mounjaro was recently approved for diabetes and is awaiting FDA approval for the primary treatment of obesity. Based on the results of the SURMOUNT trial, tirzepatide will likely be the most effective obesity medication EVER. This once per week injection produced an average weight loss of nearly 21% of body weight at 72 weeks. In this video, Dr. Christopher McGowan, MD, MSCR, of True You Weight Loss, explains how tirzepatide (Mounjaro) works, common side effects, expectations, and a comparison to other weight loss medications. #obesitytreatment #obesity #weightloss #weightlosstreatment
Related Videos :
- 10000 Step FAST Walking Workout | 1 Hour Fat Burning Endurance [cxSMGTGuB]
- Ana Navarro The View Reacts to Morning Joe Talk Show Sit Down With Trump [w7YvxMLT4]
- Protein for Aging Muscles: Latest Research | Justin Keogh | The Proof Clips EP #301 [WDwTPEWVA]
- #Weight loss figure exercise at home inspiration #short [y4rpotZmJ]
- Weight Loss Dosa | Oats Beetroot Dosa #cheela #dosa [OsIYa63aj]
Aired: December 3rd 2024
Buy Now:
Problems Playing Video? | Closed Captioning